Methylphenidate Controlled-Release Tablets and Perflutren Protein Type A
Determining the interaction of Methylphenidate Controlled-Release Tablets and Perflutren Protein Type A and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methylphenidate Controlled-Release Tablets-Perflutren protein type a microsphere Intravenous
- Methylphenidate Controlled-Release Tablets-Perforomist
- Methylphenidate Controlled-Release Tablets-Perforomist, Symbicort
- Methylphenidate Controlled-Release Tablets-Pergolide
- Methylphenidate Controlled-Release Tablets-Pergonal
- Methylphenidate Controlled-Release Tablets-Peri-Colace
- Perflutren Protein Type A-Methylphenidate ER Capsules
- Perflutren Protein Type A-Methylphenidate Extended-Release Capsules (Evening Formulation)
- Perflutren Protein Type A-Methylphenidate Extended-Release Chewable Tablets
- Perflutren Protein Type A-Methylphenidate Extended-Release Oral Suspension
- Perflutren Protein Type A-Methylphenidate Extended-Release Oral-Disintegrating Tablets
- Perflutren Protein Type A-Methylphenidate Extended-Release Tablets